Series D - BIND Therapeutics
Investment Firm
Overview
BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Announced Date
Feb 13, 2012
Funding Type
Series D
Highlights
Location
United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
 RUSNANO |
Round Details and Background
BIND Therapeutics raised $25500000 on 2012-02-13 in Series D
BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Feb 11, 2013 |  Venture Round - BIND Therapeutics | - | 8.7M | |
| Feb 13, 2012 | Series D - BIND Therapeutics | 1 | - | 25.5M |
| Oct 13, 2011 | Debt Financing - BIND Therapeutics | - | 4.8M | |
| Jun 29, 2010 | Series C - BIND Therapeutics | 5 | - | 12.4M |
Recent Activity
There is no recent news or activity for this profile.